JP2015526443A5 - - Google Patents

Download PDF

Info

Publication number
JP2015526443A5
JP2015526443A5 JP2015527569A JP2015527569A JP2015526443A5 JP 2015526443 A5 JP2015526443 A5 JP 2015526443A5 JP 2015527569 A JP2015527569 A JP 2015527569A JP 2015527569 A JP2015527569 A JP 2015527569A JP 2015526443 A5 JP2015526443 A5 JP 2015526443A5
Authority
JP
Japan
Prior art keywords
chloro
indazol
benzoyl
trifluoromethyl
cyclohex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015527569A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015526443A (ja
JP6232429B2 (ja
Filing date
Publication date
Priority claimed from PCT/CN2012/080133 external-priority patent/WO2014026328A1/en
Application filed filed Critical
Publication of JP2015526443A publication Critical patent/JP2015526443A/ja
Publication of JP2015526443A5 publication Critical patent/JP2015526443A5/ja
Application granted granted Critical
Publication of JP6232429B2 publication Critical patent/JP6232429B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015527569A 2012-08-15 2013-08-14 RORγT阻害剤としての3−シクロヘキセニルおよびシクロヘキシル置換インドールおよびインダゾール化合物およびそれらの使用 Expired - Fee Related JP6232429B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/CN2012/080133 WO2014026328A1 (en) 2012-08-15 2012-08-15 3-cyclohexenyl substituted indole and indazole compounds as rorgammat inhibitors and uses thereof
CNPCT/CN2012/080133 2012-08-15
PCT/US2013/054902 WO2014028597A2 (en) 2012-08-15 2013-08-14 3-CYCLOHEXENYL AND CYCLOHEXYL SUBSTITUTED INDOLE AND INDAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF

Publications (3)

Publication Number Publication Date
JP2015526443A JP2015526443A (ja) 2015-09-10
JP2015526443A5 true JP2015526443A5 (cg-RX-API-DMAC7.html) 2016-09-23
JP6232429B2 JP6232429B2 (ja) 2017-11-15

Family

ID=50101186

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015527569A Expired - Fee Related JP6232429B2 (ja) 2012-08-15 2013-08-14 RORγT阻害剤としての3−シクロヘキセニルおよびシクロヘキシル置換インドールおよびインダゾール化合物およびそれらの使用

Country Status (22)

Country Link
US (1) US9487490B2 (cg-RX-API-DMAC7.html)
EP (1) EP2884976B1 (cg-RX-API-DMAC7.html)
JP (1) JP6232429B2 (cg-RX-API-DMAC7.html)
KR (1) KR20150041800A (cg-RX-API-DMAC7.html)
CN (1) CN104822376A (cg-RX-API-DMAC7.html)
AU (1) AU2013302644A1 (cg-RX-API-DMAC7.html)
BR (1) BR112015003332A2 (cg-RX-API-DMAC7.html)
CA (1) CA2881696A1 (cg-RX-API-DMAC7.html)
CY (1) CY1122272T1 (cg-RX-API-DMAC7.html)
DK (1) DK2884976T3 (cg-RX-API-DMAC7.html)
ES (1) ES2749713T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20191654T1 (cg-RX-API-DMAC7.html)
HU (1) HUE045379T2 (cg-RX-API-DMAC7.html)
LT (1) LT2884976T (cg-RX-API-DMAC7.html)
ME (1) ME03579B (cg-RX-API-DMAC7.html)
PL (1) PL2884976T3 (cg-RX-API-DMAC7.html)
PT (1) PT2884976T (cg-RX-API-DMAC7.html)
RS (1) RS59364B1 (cg-RX-API-DMAC7.html)
RU (1) RU2015108898A (cg-RX-API-DMAC7.html)
SI (1) SI2884976T1 (cg-RX-API-DMAC7.html)
SM (1) SMT201900580T1 (cg-RX-API-DMAC7.html)
WO (2) WO2014026328A1 (cg-RX-API-DMAC7.html)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2487159A1 (en) 2011-02-11 2012-08-15 MSD Oss B.V. RorgammaT inhibitors
WO2014026327A1 (en) 2012-08-15 2014-02-20 Merck Sharp & Dohme Corp. 4-heteroaryl substituted benzoic acid compounds as rorgammat inhibitors and uses thereof
WO2014026329A1 (en) 2012-08-15 2014-02-20 Merck Sharp & Dohme Corp. N-alkylated indole and indazole compounds as rorgammat inhibitors and uses thereof
WO2014026330A1 (en) 2012-08-15 2014-02-20 Merck Sharp & Dohme Corp. 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
CU24398B1 (es) * 2013-08-02 2019-04-04 Pfizer 3-(piperidin,pirrol o azetidin)-indoles sustituidos útiles como inhibidores rorc2
DK3102576T3 (da) 2014-02-03 2019-07-22 Vitae Pharmaceuticals Llc Dihydropyrrolopyridininhibitorer af ror-gamma
AU2015222917A1 (en) 2014-02-27 2016-09-15 Lycera Corporation Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma and related therapeutic methods
EP3140291A4 (en) 2014-05-05 2018-01-10 Lycera Corporation Tetrahydroquinoline sulfonamide and related compounds for use as agonists of rory and the treatment of disease
WO2015171558A2 (en) 2014-05-05 2015-11-12 Lycera Corporation BENZENESULFONAMIDO AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORγ AND THE TREATEMENT OF DISEASE
US9701663B2 (en) 2014-07-25 2017-07-11 Innov17 Llc Sulfonamide retinoic acid receptor-related orphan receptor modulators and uses thereof
US9771374B2 (en) * 2014-07-25 2017-09-26 Innov17 Llc Benzimidazole retinoic acid receptor-related orphan receptor modulators and uses thereof
US20160024086A1 (en) * 2014-07-25 2016-01-28 Innov17 Llc Azaindole retinoic acid receptor-related orphan receptor modulators and uses thereof
US20160024057A1 (en) 2014-07-25 2016-01-28 Innov17 Llc Indazole retinoic acid receptor-related orphan receptor modulators and uses thereof
MA40759A (fr) 2014-09-26 2017-08-01 Pfizer Modulateurs de rorc2 de type pyrrolopyridine substitué par un méthyle et trifluorométhyle et leurs procédés d'utilisation
SI3207043T1 (sl) 2014-10-14 2019-04-30 Vitae Pharmaceuticals, Inc. Dihidropirolopiridinovi inhibitorji za ROR-gama
GB201419015D0 (en) 2014-10-24 2014-12-10 Orca Pharmaceuticals Ltd Compounds
US9845308B2 (en) 2014-11-05 2017-12-19 Vitae Pharmaceuticals, Inc. Isoindoline inhibitors of ROR-gamma
US9663515B2 (en) 2014-11-05 2017-05-30 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ROR-gamma
US10435402B2 (en) * 2015-01-08 2019-10-08 Advinus Therapeutics Limited Bicyclic compounds, compositions and medicinal applications thereof
JP6449470B2 (ja) * 2015-01-28 2019-01-09 北京韓美薬品有限公司 N−安息香酸基置換のベンゾピロリン−2−オン誘導体及びその用途
WO2016120850A1 (en) * 2015-01-30 2016-08-04 Pfizer Inc. Sulfonamide-subsituted indole modulators of rorc2 and methods of use thereof
CA2975997A1 (en) 2015-02-11 2016-08-18 Merck Sharp & Dohme Corp. Substituted pyrazole compounds as rorgammat inhibitors and uses thereof
WO2016128908A1 (en) * 2015-02-12 2016-08-18 Advinus Therapeutics Limited Bicyclic compounds, compositions and medicinal applications thereof
CN107614062A (zh) 2015-03-12 2018-01-19 加利福尼亚大学董事会 用RORγ抑制剂治疗癌症的方法
WO2016179343A1 (en) 2015-05-05 2016-11-10 Lycera Corporation DIHYDRO-2H-BENZO[b][1,4]OXAZINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORy AND THE TREATMENT OF DISEASE
JP6549735B2 (ja) * 2015-06-09 2019-07-24 アッヴィ・インコーポレイテッド 核内受容体調節剤
WO2016198908A1 (en) * 2015-06-09 2016-12-15 Abbvie Inc. Ror nuclear receptor modulators
CN107980042B (zh) 2015-06-11 2021-10-08 莱斯拉公司 用作RORγ激动剂和用于治疗疾病的芳基二氢-2H-苯并[b][1,4]噁嗪磺酰胺和相关化合物
EP3331876B1 (en) 2015-08-05 2020-10-07 Vitae Pharmaceuticals, LLC Modulators of ror-gamma
JO3638B1 (ar) * 2015-09-09 2020-08-27 Lilly Co Eli مركبات مفيدة في تثبيط ror - جاما- t
EP3368516B1 (en) * 2015-10-27 2020-07-15 Merck Sharp & Dohme Corp. SUBSTITUTED BICYCLIC PYRAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
JP2018531958A (ja) 2015-10-27 2018-11-01 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. RORγT阻害薬としてのヘテロアリール置換安息香酸及びその使用
US10287272B2 (en) 2015-10-27 2019-05-14 Merck Sharp & Dohme Corp. Substituted indazole compounds as RORgammaT inhibitors and uses thereof
EP3868750A1 (en) 2015-11-20 2021-08-25 Vitae Pharmaceuticals, LLC Modulators of ror-gamma
TWI757266B (zh) 2016-01-29 2022-03-11 美商維它藥物有限責任公司 ROR-γ調節劑
US9481674B1 (en) 2016-06-10 2016-11-01 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ROR-gamma
EP3562828B1 (en) 2016-12-28 2026-03-18 Dart Neuroscience LLC Substituted pyrazolopyrimidinone compounds as pde2 inhibitors
JP2020111510A (ja) * 2017-03-29 2020-07-27 科研製薬株式会社 インダゾール誘導体及びそれを含有する医薬
KR102615821B1 (ko) * 2017-04-11 2023-12-21 선샤인 레이크 파르마 컴퍼니 리미티드 불소-치환된 인다졸 화합물 및 이의 용도
RU2742770C1 (ru) * 2017-07-06 2021-02-10 Цзянсу Хэнжуй Медицин Ко., Лтд. Производное индола и формамида, способ его получения и применение в медицине
WO2019018975A1 (en) 2017-07-24 2019-01-31 Vitae Pharmaceuticals, Inc. INHIBITORS OF ROR GAMMA
CN115716826A (zh) 2017-07-24 2023-02-28 生命医药有限责任公司 RORγ的抑制剂
MX2020005447A (es) 2017-11-27 2020-12-03 Dart Neuroscience Llc Compuestos de furanopirimidina sustituida como inhibidores de pde1.
US20240066027A1 (en) * 2020-12-03 2024-02-29 Domain Therapeutics Novel par-2 inhibitors
CN120418228A (zh) * 2023-01-09 2025-08-01 康百达(四川)生物医药科技有限公司 一种杂环化合物及其在医药上的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT95899A (pt) * 1989-11-17 1991-09-13 Glaxo Group Ltd Processo para a preparacao de derivados indole
JPH09511334A (ja) * 1994-03-30 1997-11-11 チバ−ガイギー アクチェンゲゼルシャフト Rzr受容体ファミリーを用いるスクリーニング方法
US5639780A (en) * 1995-05-22 1997-06-17 Merck Frosst Canada, Inc. N-benzyl indol-3-yl butanoic acid derivatives as cyclooxygenase inhibitors
US6716452B1 (en) * 2000-08-22 2004-04-06 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
GT200500208A (es) * 2004-08-03 2006-03-02 Indazoles ùtiles para tratar enfermedades cardiovasculares
BRPI0515532A (pt) * 2004-09-21 2008-07-29 Athersys Inc composto, composição farmacêutica, métodos de inibir a ligação de ligandos endógenos ao receptor de crth-2 em uma célula, de tratar, melhorar ou prevenir um distúrbio responsivo à inibição da ligação de ligandos endógenos ao receptor de crt-2 e de preparar um composto, e, kit
EP1828180A4 (en) 2004-12-08 2010-09-15 Glaxosmithkline Llc 1H-pyrrolo [2,3-BETA] PYRIDINE
EP2181710A1 (en) 2008-10-28 2010-05-05 Phenex Pharmaceuticals AG Ligands for modulation of orphan receptor-gamma (NR1F3) activity
EP2459184A1 (en) * 2009-07-31 2012-06-06 The Brigham and Women's Hospital, Inc. Modulation of sgk1 expression in th17 cells to modulate th17-mediated immune responses
WO2011055270A1 (en) * 2009-11-04 2011-05-12 Wyeth Llc Indole based receptor crth2 antagonists
EP2487159A1 (en) * 2011-02-11 2012-08-15 MSD Oss B.V. RorgammaT inhibitors
JP2014166961A (ja) * 2011-06-20 2014-09-11 Dainippon Sumitomo Pharma Co Ltd 新規インダゾール誘導体
WO2014026327A1 (en) * 2012-08-15 2014-02-20 Merck Sharp & Dohme Corp. 4-heteroaryl substituted benzoic acid compounds as rorgammat inhibitors and uses thereof
WO2014026329A1 (en) * 2012-08-15 2014-02-20 Merck Sharp & Dohme Corp. N-alkylated indole and indazole compounds as rorgammat inhibitors and uses thereof
WO2014026330A1 (en) * 2012-08-15 2014-02-20 Merck Sharp & Dohme Corp. 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF

Similar Documents

Publication Publication Date Title
RU2015108898A (ru) 3-ЦИКЛОГЕКСЕНИЛ И ЦИКЛОГЕКСИЛ ЗАМЕЩЕННЫЕ ИНДОЛЬНЫЕ И ИНДАЗОЛЬНЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ RORгаммаТ И ИХ ПРИМЕНЕНИЯ
JP2015526444A5 (cg-RX-API-DMAC7.html)
RU2015108933A (ru) 3-АМИНОЦИКЛОАЛКИЛЬНЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ ROBгаммаT И ИХ ПРИМЕНЕНИЯ
JP2012521994A5 (cg-RX-API-DMAC7.html)
JP2013510124A5 (cg-RX-API-DMAC7.html)
JP2013542261A5 (cg-RX-API-DMAC7.html)
RU2388761C2 (ru) Производные тиенопиридина в качестве аллостерических энхансеров гамк-в
JP2018519323A5 (cg-RX-API-DMAC7.html)
JP2011528658A5 (cg-RX-API-DMAC7.html)
JP2015526441A5 (cg-RX-API-DMAC7.html)
JP2009523760A5 (cg-RX-API-DMAC7.html)
JP2014511893A5 (cg-RX-API-DMAC7.html)
RU2015112914A (ru) Бензимидазолы в качестве активных агентов для центральной нервной системы
JP2014511892A5 (cg-RX-API-DMAC7.html)
JP2014507455A5 (cg-RX-API-DMAC7.html)
JP2010539110A5 (cg-RX-API-DMAC7.html)
JP2016507581A5 (cg-RX-API-DMAC7.html)
JP2017528506A5 (cg-RX-API-DMAC7.html)
JP2018527295A5 (cg-RX-API-DMAC7.html)
JP2011511089A5 (cg-RX-API-DMAC7.html)
RU2015155585A (ru) 4-алкинилимидазольное производное и лекарственное средство, включающее такое производное в качестве активного ингредиента
JP2015501820A5 (cg-RX-API-DMAC7.html)
PE20141167A1 (es) Piridopirazinas sustituidas como inhibidores novedosos de ptk
JP2016500068A5 (cg-RX-API-DMAC7.html)
JP2019513755A5 (cg-RX-API-DMAC7.html)